Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2253
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study ; volume:21 ; number:1 ; day:17 ; month:8 ; year:2021 ; pages:1-9 ; date:12.2021
BMC anesthesiology ; 21, Heft 1 (17.8.2021), 1-9, 12.2021
- Creator
-
Fábián, Ákos I.
Tassonyi, Edömér
Csernoch, Vera
Fedor, Marianna
Sohajda, Tamás
Szente, Lajos
Fülesdi, Béla
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12871-021-01424-4
- URN
-
urn:nbn:de:101:1-2021110518212135958651
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fábián, Ákos I.
- Tassonyi, Edömér
- Csernoch, Vera
- Fedor, Marianna
- Sohajda, Tamás
- Szente, Lajos
- Fülesdi, Béla
- SpringerLink (Online service)
Other Objects (12)
Neuromuscular blockers and their reversal: have we finally found the on-off switches?
Observational study on patterns of neuromuscular blockade reversal
Neuromuscular junction
Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
Immune mediated neuromuscular diseases
Neuromuscular disease: 2021 update
Neuromuscular disease: 2023 update
Neuromuscular Components of Endurance
Neuromuscular disease: 2022 update
Electrical stimulation and neuromuscular disorders
Visual Analysis of Neuromuscular Junctions
Neuromuscular blockers and their reversal: have we finally found the on-off switches?
Observational study on patterns of neuromuscular blockade reversal
Neuromuscular junction
Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
Immune mediated neuromuscular diseases
Neuromuscular disease: 2021 update
Neuromuscular disease: 2023 update
Neuromuscular Components of Endurance
Neuromuscular disease: 2022 update
Electrical stimulation and neuromuscular disorders
Visual Analysis of Neuromuscular Junctions
Neuromuscular blockers and their reversal: have we finally found the on-off switches?
Observational study on patterns of neuromuscular blockade reversal
Neuromuscular junction
Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study
Immune mediated neuromuscular diseases
Neuromuscular disease: 2021 update
Neuromuscular disease: 2023 update
Neuromuscular Components of Endurance
Neuromuscular disease: 2022 update
Electrical stimulation and neuromuscular disorders